All In MedTech

Device Trial Radar · NCT03775980

CIRSE Emprint Microwave Ablation Registry

Last checked: Nov 19, 2026Latest source record: May 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

500

Actual

Start

Sep 4, 2019

Primary completion

Jan 3, 2023

Study completion Jan 31, 2026

Sponsor

Sponsor type
Academic, hospital or other
Collaborators
Medtronic
First posted
Dec 14, 2018

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 99 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Observation of the clinical use of the Emprint Microwave Ablation System for the ablation of Liver Metastases of Colorectal Adenocarcinoma.

Conditions

  • Colorectal Neoplasms Malignant
  • Neoplasm Metastasis

Interventions

  • Emprint Microwave Ablation SystemDevice

    Microwave Ablation of colorectal liver metastases

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Local Tumor ControlTime frame: 12 months

Locations

38 sites in 13 countries. Site status is shown where the registry gives one.

  • University Hospital Centre Sisters of Mercy

    Zagreb, Croatia

  • Aarhus University Hospital

    Aarhus, Denmark

  • University Hospital of Nimes

    Nîmes, France

35 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.